A journal of the American College of Rheumatology.

Gillian Hawker, a rheumatologist and scientific epidemiologist at the University of Toronto in Canada. ‘Our overview of available pain questionnaires provides both clinicians and experts with an instant reference for comparing and selecting the most appropriate assessment tool because of their purpose.’ Details regarding questionnaire content, ease of use, and measurement properties are contained in the review of each questionnaire. Related StoriesArthritis patients to be greater contributors to clinical guideline developmentCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyAddressing standard of living needs in prostate cancer: an interview with Professor Louis DenisThe authors present a review of generic uni – and multi-dimensional pain assessment equipment like the Visual Analog Level, Numeric Rating Scale, Short-form McGill Pain Questionnaire, Chronic Pain Quality Scale, Short Form-36 Bodily Pain Scale, and the Way of measuring Intermittent and Regular Osteoarthritis Pain.‘We recently initiated a new Phase III trial in Parkinson’s disease psychosis and we are continuing to plan for a Stage II feasibility research in Alzheimer’s disease psychosis and a Stage III co-therapy trial in schizophrenia. We believe that pimavanserin along with ACADIA’s other product applicants placement us with multiple attractive product and commercial possibilities providing significant growth potential.’ Related StoriesReduced conflict-related brain activity linked to higher risk for psychosisArticle explores viewpoints on function of gentle cognitive impairment in Parkinson's diseaseGene therapy prevents neuronal loss of life, disease results in experimental style of PDRevenues risen to $2.3 million for the next quarter of 2010 from $1.8 million for the next quarter of 2009.